Trillium Therapeutics Inc. Gains 44.66%

Thu 02 Jan 20 at 05:30 PM
Trillium Therapeutics Inc. Gains 44.66%

Trillium Therapeutics Inc. (TRIL:NASDAQ) soared at $1.49, representing a gain of 44.7%. From Tue 10 Dec 19, the stock recorded 71.43% Up Days and 73.33% Green Days

About Trillium Therapeutics Inc. (TRIL:NASDAQ)

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.

Share